Endograft infection by Proteus, Pseudomonas, Enterococcus faecium and Candida albicans

Authors

  • Marta Teresa Matia Sanz Hospital Royo Villanova
  • Isabel Fiteni Mera Hospital Royo Villanova
  • Soledad Isasi de Isasmendi Perez Hospital Royo Villanova https://orcid.org/0000-0001-6246-9072
  • Martín Gericó Aseguinolaza Hospital Royo Villanova
  • Laura Peiro Muntadas Hospital Royo Villanova
  • Paula Aragonés Pequerul Hospital Royo Villanova

DOI:

https://doi.org/10.22585/hospdomic.v8i2.208

Keywords:

Vascular Grafting, Anti-Bacterial Agents, Home Care

Abstract

Hospitalization at home (HaD) is a safe and effective care modality for multiple pathologies, among which infections that require prolonged intravenous antibiotic therapy stand out. The case presented deals with a patient with a prolonged hospital stay due to an endovascular graft infection with multiple complications and the involvement of multi-resistant microorganisms for which there was no oral antibiotic alternative. After being admitted to the Vascular Surgery ward for 6 months, he was transferred to Hospitalization at home to complete TADE. During this admission, the prescribed antibiotic regimen was continued, resulting in several complications that required treatment adjustment, including the change of antibiotic therapy to IV Meropenem, which was administered in an auto-TADE regimen. After 7 months of admission to HaD, the patient was successfully discharged, demonstrating the benefits of this care alternative in cases such as the one described.

Downloads

Download data is not yet available.

References

González-Ramallo VJ, Mirón-Rubio M, Mujal A, Estrada O, Forné C, Aragón B, Rivera AJ. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain. Int J Antimicrob Agents 2017;50(1):114-8. DOI: 10.1016/j.ijantimicag.2017.02.017

Wouthuyzen-Bakker M, Van Oosten M, Bierman W, Winter R, Glaudemans A, Slart R, Toren-Wielema M, Tielliu I, Zeebregts C.J,. Prakken N H.J, de Vries JP, Saleem B R. Diagnosis and treatment of vascular graft and endograft infections: a structured clinical approach. Int J Infect Dis. 2023:126:22-7. DOI: 10.1016/j.ijid.2022.11.011

Chakfé N, Diener H, Lejay A, Assadian O, et al. Editor’s Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections. Eur J Vasc Endovasc Surg. 2020;59(3):339-84. DOI: 10.1016/j.ejvs.2019.10.016

Dominguez-Cainzos J, Rodrigo-Manjon A, Rodriguez-Chinesta JM, Apodaka-Diez A, Bonmatí G, Bereciartua E. Abdominal aortic endograft infection. A decade of experience and literature review. Enferm Infecc Microbiol Clin (Engl Ed). 2021:S0213-005X(21)00219-6. DOI: 10.1016/j.eimc.2021.06.018

Manning L, Wright C , Ingram PR. Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stability. PLoS One. 2014;14;9(7):e102023. DOI: 10.1371/journal.pone.0102023

Dubois-Silva A, Otero-Plaza L, Dopico-Santamariña L, et al. Outpatient parenteral antimicrobial therapy with continuous infusion of meropenem: A retrospective analysis of three years of clinical experience. Enferm Infecc Microbiol Clin (Engl Ed). 2023;41(6):321-8. DOI: 10.1016/j.eimce.2021.11.012

Downloads

Published

2024-06-30

How to Cite

Matia Sanz, M. T., Fiteni Mera, I., Isasi de Isasmendi Perez, S. ., Gericó Aseguinolaza, M., Peiro Muntadas, L., & Aragonés Pequerul, P. (2024). Endograft infection by Proteus, Pseudomonas, Enterococcus faecium and Candida albicans. Hospital a Domicilio, 8(2), 85–90. https://doi.org/10.22585/hospdomic.v8i2.208

Issue

Vol. 8 No. 2 (2024)

Section

Notas clínicas

License

Copyright (c) 2024 Marta Teresa Matia Sanz, Isabel Fiteni Mera, Soledad Isasi de Isasmendi Perez, Martín Gericó Aseguinolaza, Laura Peiro Muntadas, Paula Aragonés Pequerul

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes: 

  1. Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons 4.0 BY-NC-SA que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
  2. Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
  3. Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).